Skip to content
207.878.2770mail@immucell.com
Immucell
Immediate Immunity™
Immucell
  • About ImmuCell
    • About ImmuCell
    • Our Purpose
    • Management and Directors
    • Career Opportunities
    • Contact Us
  • First Defense
    • Product Line Overview
    • Manufacturing Facility Expansion
    • Manufacturing Facility Virtual Tour
    • Testimonials
  • Sales & Distributors
    • Sales Team
    • Distributors
  • News
  • Investors
  • About ImmuCell
    • About ImmuCell
    • Our Purpose
    • Management and Directors
    • Career Opportunities
    • Contact Us
  • First Defense
    • Product Line Overview
    • Manufacturing Facility Expansion
    • Manufacturing Facility Virtual Tour
    • Testimonials
  • Sales & Distributors
    • Sales Team
    • Distributors
  • News
  • Investors

STOCK QUOTE

PRESS RELEASES

Recent News | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014
SEC FILINGS
SEC FIlings

XBRL Documents

Annual Report and Proxy
CORPORATE GOVERNANCE
ICCC Code of Conduct

Charter and Powers of the Audit Committee

Nominating Committee Charter

Management & Directors

2016 Press Releases

11-10-2016 ImmuCell Announces Third Quarter 2016 Financial Results

11-10-2016 ImmuCell to Present at the 7th Annual Craig-Hallum Alpha Select Conference

11-03-2016 ImmuCell to Announce Third Quarter 2016 Financial Results

10-21-2016 ImmuCell Corporation Announces Closing of $3.5 Million Private Placement of Common Stock

10-18-2016 ImmuCell to Raise $3.5 Million in Private Placement

10-18-2016 ImmuCell Announces Preliminary Third Quarter 2016 Financial Results

10-11-2016 ImmuCell Breaks Ground for Mast Out® Facility

08-11-2016 ImmuCell Announces Second Quarter 2016 Financial Results

08-03-2016 ImmuCell to Announce Second Quarter 2016 Financial Results

5-11-2016 ImmuCell to Announce First Quarter 2016 Financial Results

5-4-2016 ImmuCell to Announce First Quarter 2016 Financial Results

4-4-2016 Immucell Appoints Elizabeth Williams Vice President of Manufacturing Operations

2-10-2016 ImmuCell Announces Full Year 2015 Financial Results

2-04-2016 ImmuCell to Announce 2015 Financial Results

2-03-2016 ImmuCell Corporation Announces Closing of $5.9 Million Public Offering of Common Stock

1-29-2016 ImmuCell Corporation Announces Pricing of $5.9 million Public Offering of Common Shares

1-28-2016 ImmuCell Corporation Announces Proposed Public Offering

1-06-2016 ImmuCell Acquires Certain Assets from Minnesota Firm

COMPANY CONTACT

Olivier te Boekhorst
President & CEO
investor.relations@immucell.com

INVESTOR CONTACT
Lytham Partners, LLC
iccc@lythampartners.com
602.889.9700

Contact Us

56 Evergreen Drive
Portland, ME 04103

Office: 207.878.2770

Sales: 1.800.IMMUCELL

mail@immucell.com

NASDAQ: ICCC

Privacy Policy
Terms of Use

Recent News

12-24-25 ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®

11-13-25 ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025

11-06-25 ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025

Follow Us

Find us on:

Facebook page opens in new windowYouTube page opens in new window
Copyright © 2020 ImmuCell Corporation
  • Home
  • About ImmuCell
  • First Defense
  • Sales Team
  • Distributors
  • News
  • Investors
  • Contact Us
Footer Menu
Go to Top
Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset